Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Eun Yang is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
09/23/2024 | UTHR | Buy Now | United Therapeutics | $317.50 | 36.06% | Eun Yang34% | $315 → $432 | Maintains | Buy | Get Alert |
06/17/2024 | AVTE | Buy Now | Aerovate Therapeutics | $2.51 | -20.32% | Eun Yang34% | $65 → $2 | Downgrade | Buy → Hold | Get Alert |
05/14/2024 | TSHA | Buy Now | Taysha Gene Therapies | $1.77 | 351.98% | Eun Yang34% | $2 → $8 | Assumes | Hold → Buy | Get Alert |
04/29/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Eun Yang34% | $26 → $25.6 | Downgrade | Buy → Hold | Get Alert |
03/25/2024 | ATXS | Buy Now | Astria Therapeutics | $6.10 | 342.62% | Eun Yang34% | $22 → $27 | Maintains | Buy | Get Alert |
03/25/2024 | AVTE | Buy Now | Aerovate Therapeutics | $2.51 | 2489.64% | Eun Yang34% | $21 → $65 | Assumes | Buy → Buy | Get Alert |
02/07/2024 | RLYB | Buy Now | Rallybio | $0.65 | 131.62% | Eun Yang34% | $7 → $1.5 | Downgrade | Buy → Hold | Get Alert |
12/15/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Eun Yang34% | $170 → $18 | Downgrade | Buy → Hold | Get Alert |
07/18/2023 | BBIO | Buy Now | BridgeBio Pharma | $36.78 | -10.29% | Eun Yang34% | $24 → $33 | Downgrade | Buy → Hold | Get Alert |
06/26/2023 | BMEA | Buy Now | Biomea Fusion | $2.69 | 940.89% | Eun Yang34% | $36 → $28 | Downgrade | Buy → Hold | Get Alert |
03/29/2023 | ELVN | Buy Now | Enliven Therapeutics | $21.32 | 26.64% | Eun Yang34% | → $27 | Initiates | → Buy | Get Alert |
02/10/2023 | GNSS | Buy Now | Genasys | $2.75 | 154.55% | Eun Yang34% | $6 → $7 | Maintains | Outperform | Get Alert |
02/01/2023 | TSHA | Buy Now | Taysha Gene Therapies | $1.77 | -15.25% | Eun Yang34% | $14 → $1.5 | Downgrade | Buy → Hold | Get Alert |
01/11/2023 | ALBO | Buy Now | Albireo Pharma | — | — | Eun Yang34% | $49 → $42 | Downgrade | Buy → Hold | Get Alert |
01/09/2023 | CVAC | Buy Now | CureVac | $2.95 | — | Eun Yang34% | — | Upgrade | Hold → Buy | Get Alert |
12/08/2022 | LUMO | Buy Now | Lumos Pharma | — | — | Eun Yang34% | $17 → $7 | Downgrade | Buy → Hold | Get Alert |
11/15/2022 | LUMO | Buy Now | Lumos Pharma | — | — | Eun Yang34% | → $7 | Downgrade | Buy → Hold | Get Alert |
11/14/2022 | PRME | Buy Now | Prime Medicine | $1.81 | 1281.22% | Eun Yang34% | → $25 | Initiates | → Buy | Get Alert |
09/22/2022 | NCNA | Buy Now | NuCana | $0.78 | 283.34% | Eun Yang34% | $525 → $75 | Maintains | Buy | Get Alert |
08/22/2022 | BPMC | Buy Now | Blueprint Medicines | $92.10 | -8.79% | Eun Yang34% | $78 → $84 | Maintains | Buy | Get Alert |
06/01/2022 | BPMC | Buy Now | Blueprint Medicines | $92.10 | -15.31% | Eun Yang34% | $88 → $78 | Upgrade | Hold → Buy | Get Alert |
05/24/2022 | UTHR | Buy Now | United Therapeutics | $317.50 | -22.83% | Eun Yang34% | $223 → $245 | Maintains | Buy | Get Alert |
11/02/2021 | PYXS | Buy Now | Pyxis Oncology | $1.18 | 2024.95% | Eun Yang34% | → $25 | Initiates | → Buy | Get Alert |
09/29/2021 | ATXS | Buy Now | Astria Therapeutics | $6.10 | 227.87% | Eun Yang34% | → $20 | Initiates | → Buy | Get Alert |
08/23/2021 | RLYB | Buy Now | Rallybio | $0.65 | 2988.33% | Eun Yang34% | → $20 | Initiates | → Buy | Get Alert |
07/26/2021 | AVTE | Buy Now | Aerovate Therapeutics | $2.51 | 736.65% | Eun Yang34% | → $21 | Initiates | → Buy | Get Alert |
07/12/2021 | VERV | Buy Now | Verve Therapeutics | $5.80 | — | Eun Yang34% | — | Initiates | → Buy | Get Alert |
06/22/2021 | CNTA | Buy Now | Centessa Pharmaceuticals | $15.10 | 131.79% | Eun Yang34% | → $35 | Initiates | → Buy | Get Alert |
05/11/2021 | BMEA | Buy Now | Biomea Fusion | $2.69 | 866.54% | Eun Yang34% | → $26 | Initiates | → Buy | Get Alert |
05/04/2021 | RPHM | Buy Now | Reneo Pharmaceuticals | — | — | Eun Yang34% | → $240 | Initiates | → Buy | Get Alert |
03/05/2021 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Eun Yang34% | → $38 | Downgrade | Buy → Hold | Get Alert |
11/02/2020 | BPMC | Buy Now | Blueprint Medicines | $92.10 | 4.23% | Eun Yang34% | → $96 | Downgrade | Buy → Hold | Get Alert |
09/08/2020 | CVAC | Buy Now | CureVac | $2.95 | 1866.1% | Eun Yang34% | → $58 | Initiates | → Hold | Get Alert |
04/16/2020 | LUMO | Buy Now | Lumos Pharma | — | — | Eun Yang34% | → $12 | Initiates | → Buy | Get Alert |
03/10/2020 | UTHR | Buy Now | United Therapeutics | $317.50 | -61.26% | Eun Yang34% | $115 → $123 | Upgrade | Hold → Buy | Get Alert |
08/01/2019 | UTHR | Buy Now | United Therapeutics | $317.50 | -71.65% | Eun Yang34% | → $90 | Upgrade | Underperform → Hold | Get Alert |
05/10/2019 | MLNT | Buy Now | Melinta Therapeutics | — | — | Eun Yang34% | $14 → $5 | Downgrade | Buy → Hold | Get Alert |
01/14/2019 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Eun Yang34% | $13 → $6 | Upgrade | Underperform → Hold | Get Alert |
10/15/2018 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | → $160 | Upgrade | Hold → Buy | Get Alert |
09/11/2018 | MLNT | Buy Now | Melinta Therapeutics | — | — | Eun Yang34% | → $75 | Initiates | → Buy | Get Alert |
08/09/2018 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Eun Yang34% | $23 → $22 | Maintains | Underperform | Get Alert |
07/27/2018 | AMGN | Buy Now | Amgen | $306.94 | -28.32% | Eun Yang34% | $200 → $220 | Maintains | Buy | Get Alert |
04/20/2018 | ALBO | Buy Now | Albireo Pharma | — | — | Eun Yang34% | → $50 | Initiates | → Buy | Get Alert |
02/12/2018 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Eun Yang34% | — | Downgrade | Buy → Underperform | Get Alert |
01/23/2018 | BIVV | Buy Now | Bioverativ | — | — | Eun Yang34% | — | Downgrade | Buy → Hold | Get Alert |
11/03/2017 | RDUS | Buy Now | Radius Health | $29.08 | 6.6% | Eun Yang34% | $38 → $31 | Maintains | Hold | Get Alert |
11/03/2017 | NLNK | Buy Now | NewLink Genetics | — | — | Eun Yang34% | $26 → $25 | Maintains | Buy | Get Alert |
10/13/2017 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | — | Downgrade | Buy → Hold | Get Alert |
09/08/2017 | NLNK | Buy Now | NewLink Genetics | — | — | Eun Yang34% | — | Upgrade | Hold → Buy | Get Alert |
07/24/2017 | DOVA | Buy Now | Dova Pharmaceuticals | — | — | Eun Yang34% | → $30 | Initiates | → Buy | Get Alert |
07/24/2017 | ALRN | Buy Now | Aileron Therapeutics | — | — | Eun Yang34% | → $400 | Initiates | → Buy | Get Alert |
07/11/2017 | BIIB | Buy Now | Biogen | $139.16 | 122.77% | Eun Yang34% | → $310 | Assumes | → Hold | Get Alert |
07/11/2017 | GILD | Buy Now | Gilead Sciences | $107.80 | -25.79% | Eun Yang34% | → $80 | Assumes | → Hold | Get Alert |
04/05/2017 | AMGN | Buy Now | Amgen | $306.94 | — | Eun Yang34% | — | Downgrade | Buy → Hold | Get Alert |
03/06/2017 | UTHR | Buy Now | United Therapeutics | $317.50 | -63.46% | Eun Yang34% | → $116 | Downgrade | Hold → Underperform | Get Alert |
10/05/2016 | BIIB | Buy Now | Biogen | $139.16 | 127.08% | Eun Yang34% | $323 → $316 | Maintains | Hold | Get Alert |
09/06/2016 | GILD | Buy Now | Gilead Sciences | $107.80 | — | Eun Yang34% | — | Upgrade | Hold → Buy | Get Alert |
09/06/2016 | BIIB | Buy Now | Biogen | $139.16 | — | Eun Yang34% | — | Downgrade | Buy → Hold | Get Alert |
08/31/2016 | GILD | Buy Now | Gilead Sciences | $107.80 | -15.58% | Eun Yang34% | $93 → $91 | Maintains | Hold | Get Alert |
08/05/2016 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Eun Yang34% | $41 → $60 | Maintains | Buy | Get Alert |
07/28/2016 | AMGN | Buy Now | Amgen | $306.94 | -35.49% | Eun Yang34% | $187 → $198 | Maintains | Buy | Get Alert |
02/24/2016 | RDUS | Buy Now | Radius Health | $29.08 | 27.24% | Eun Yang34% | → $37 | Downgrade | Buy → Hold | Get Alert |
10/30/2015 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | — | Assumes | → Buy | Get Alert |
08/07/2015 | RDUS | Buy Now | Radius Health | $29.08 | 171.66% | Eun Yang34% | $66 → $79 | Maintains | Buy | Get Alert |
04/29/2015 | UTHR | Buy Now | United Therapeutics | $317.50 | -51.18% | Eun Yang34% | $143 → $155 | Maintains | Hold | Get Alert |
04/02/2015 | NLNK | Buy Now | NewLink Genetics | — | — | Eun Yang34% | → $50 | Downgrade | Buy → Hold | Get Alert |
03/11/2015 | RDUS | Buy Now | Radius Health | $29.08 | 92.57% | Eun Yang34% | $45 → $56 | Maintains | Buy | Get Alert |
03/10/2015 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | $240 → $120 | Downgrade | Buy → Hold | Get Alert |
02/27/2015 | NLNK | Buy Now | NewLink Genetics | — | — | Eun Yang34% | $36 → $50 | Maintains | Buy | Get Alert |
02/25/2015 | UTHR | Buy Now | United Therapeutics | $317.50 | -54.96% | Eun Yang34% | $120 → $143 | Maintains | Hold | Get Alert |
01/16/2015 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Eun Yang34% | $28 → $32 | Maintains | Buy | Get Alert |
08/12/2014 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | $340 → $320 | Maintains | Buy | Get Alert |
08/04/2014 | LJPC | Buy Now | La Jolla Pharmaceutical | — | — | Eun Yang34% | → $25 | Initiates | → Buy | Get Alert |
07/16/2014 | RDUS | Buy Now | Radius Health | $29.08 | -41.54% | Eun Yang34% | → $17 | Initiates | → Buy | Get Alert |
10/14/2013 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Eun Yang34% | → $20 | Initiates | → Buy | Get Alert |
08/13/2013 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | $260 → $280 | Maintains | Buy | Get Alert |
06/18/2013 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | $160 → $260 | Maintains | Buy | Get Alert |
06/13/2013 | NLNK | Buy Now | NewLink Genetics | — | — | Eun Yang34% | → $29 | Initiates | → Buy | Get Alert |
04/08/2013 | ACRX | Buy Now | AcelRx Pharmaceuticals | — | — | Eun Yang34% | → $160 | Initiates | → Buy | Get Alert |
02/26/2013 | UTHR | Buy Now | United Therapeutics | $317.50 | -83.62% | Eun Yang34% | $45 → $52 | Maintains | Hold | Get Alert |